These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3760386)

  • 1. Application of information theory to decision analysis in potentially prostaglandin-responsive neonates.
    Danford DA; Gutgesell HP; McNamara DG
    J Am Coll Cardiol; 1986 Nov; 8(5):1125-30. PubMed ID: 3760386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care of the infant with ductus-dependent congenital heart disease receiving prostaglandin E1.
    Stachura L
    Issues Compr Pediatr Nurs; 1984; 7(4-5):203-15. PubMed ID: 6569057
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.
    Freed MD; Heymann MA; Lewis AB; Roehl SL; Kensey RC
    Circulation; 1981 Nov; 64(5):899-905. PubMed ID: 7285305
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
    Lewis AB; Takahashi M; Lurie PR
    J Pediatr; 1978 Sep; 93(3):481-5. PubMed ID: 690772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of clinical response to prostaglandin E1 in a cyanotic infant with congenital absence of the ductus arteriosus.
    Hamilton WT; Lacina SJ; Bharati S; Lev M; Arcilla RA
    Cathet Cardiovasc Diagn; 1982; 8(3):273-6. PubMed ID: 7201887
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin E1 in suspected ductus dependent cardiac malformation.
    Hallidie-Smith KA
    Arch Dis Child; 1984 Nov; 59(11):1020-6. PubMed ID: 6542338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
    Olley PM; Coceani F; Bodach E
    Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML
    Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of prostaglandins in neonatal cardiology].
    Dinarević S; Kurtagić S; Maksić H
    Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of prostaglandin in heart abnormalities with needed patency of the arterial canal (clinical and histological study)].
    Moulaert A; Gittenberger-De Groot A; Harinck E
    Arch Fr Pediatr; 1978; 35(7):717-25. PubMed ID: 736728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of telemedicine on the practice of pediatric cardiology in community hospitals.
    Sable CA; Cummings SD; Pearson GD; Schratz LM; Cross RC; Quivers ES; Rudra H; Martin GR
    Pediatrics; 2002 Jan; 109(1):E3. PubMed ID: 11773571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical manipulation of the ductus arteriosus.
    Elliott RB; Starling MB; Neutze JM
    Lancet; 1975 Jan; 1(7899):140-2. PubMed ID: 46053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular therapy in the newborn.
    Sandor GG
    Clin Invest Med; 1985; 8(4):360-7. PubMed ID: 3907921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
    Olley PM; Coceani F
    Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
    [No Abstract]   [Full Text] [Related]  

  • 19. Dilation of the ductus arteriosus by oral prostaglandin E1 derivative in cyanotic congenital heart diseases.
    Matsuura H; Saji T; Yamamoto S; Ishikita T; Aoki Y; Matsuo N
    Am Heart J; 1993 May; 125(5 Pt 1):1453-4. PubMed ID: 8480610
    [No Abstract]   [Full Text] [Related]  

  • 20. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.
    Heymann MA; Berman W; Rudolph AM; Whitman V
    Circulation; 1979 Jan; 59(1):169-73. PubMed ID: 758109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.